Squamous Cell Carcinoma of the Oropharynx
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Oropharynx.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck [Phase 2, Phase 3]
A Phase 2/Phase 3 trial is evaluating de-intensification of postoperative radiotherapy for head and neck squamous cell carcinomas, including…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: A Study Evaluating the Contribution of Non-Coplanar Beam Arrangement in Reducing Toxicity in Radiotherapy for Upper Aerodigestive Tract Cancers [NA]
A ClinicalTrials.gov study evaluating non-coplanar beam arrangement to reduce toxicity in radiotherapy for squamous cell carcinoma of the or…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Evaluation of Tongue Base MucOsectomy & Step sErial Sectioning
Clinical trial update on tongue base mucosectomy and serial sectioning for squamous cell carcinoma of the oropharynx. The study is currently…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial from the University of Virginia evaluating HPV DNA-guided radiotherapy to de-intensify treatment for oropharyngeal …
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze) [Phase 2]
A Phase II clinical trial at the University of Michigan Rogel Cancer Center is evaluating personalized de-escalation treatment for p16-posit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Safety and Efficacy of APG-157 in Head and Neck Cancer [Phase 2]
Phase 2 clinical trial update for APG-157 in head and neck squamous cell carcinomas; current status is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer [Phase 1]
Phase 1 clinical trial assessing the safety of delivering a standard dose of radiation over a shorter period after surgery for intermediate-…
-
CLINICAL_TRIALS research · 2024-11-13Clinical Trial Update: Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome
Clinical trial platform in head and neck carcinoma focusing on molecular and blood-based biomarkers, treatment, and outcomes is currently re…
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC [Phase 2]
Phase II study investigating cemiplimab plus ISA101b in HPV16-positive oropharyngeal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC [Phase 2]
A randomized Phase 2 trial assessing cemiplimab with or without ISA101b in HPV16-positive oropharyngeal squamous cell carcinoma is underway,…
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: A Phase II Randomized Trial for Early-stage Squamous Cell Carcinoma of the Oropharynx: Radiotherapy vs Trans-oral Robotic Surgery (ORATOR) [Phase 2]
Phase II randomized trial comparing radiotherapy to trans-oral robotic surgery for early-stage squamous cell carcinoma of the oropharynx.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma [Phase 1, Phase 2]
A Phase 1/2 study evaluating the combination of cetuximab and nivolumab in recurrent or metastatic head and neck squamous cell carcinoma has…
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx [Phase 2]
Phase 2 trial update on de-intensification treatment for squamous cell carcinoma of the oropharynx.
-
CLINICAL_TRIALS trial_result · 2022-05-26Clinical Trial Update: Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN [Phase 2]
Phase 2 trial evaluating induction TP+5-FU or TP+cetuximab followed by radioimmunotherapy for locally advanced or unresectable squamous cell…
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck [Phase 2]
Phase 2 trial evaluating erlotinib hydrochloride with radiation therapy in various Stage III-IV squamous cell carcinomas of the head and nec…
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck [Phase 2]
Phase 2 clinical trial evaluating capecitabine and lapatinib ditosylate in various forms of head and neck squamous cell carcinoma has comple…
-
CLINICAL_TRIALS trial_result · 2018-08-14Clinical Trial Update: Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel and carboplatin before radiation therapy in HPV-positive Stage III-IV oropharynx, hypopharynx, or larynx…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Swallowing, Speech and Quality of Life of Patients With Carcinoma of the Oropharynx
This clinical trial update describes swallowing, speech, and quality-of-life outcomes in patients with squamous cell carcinoma of the oropha…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat) [Phase 1]
Phase 1 study evaluating Cytochlor and tetrahydrouridine as radiosensitizers with cisplatin plus radiation in patients with advanced squamou…
-
CLINICAL_TRIALS research · 2016-06-03Clinical Trial Update: Molecular Imaging-based Dose Escalation in HPV Negative Patients With Locally Advanced SCC of the Oropharynx [NA]
Clinical trial update describing a study on molecular imaging-based dose escalation in HPV-negative locally advanced squamous cell carcinoma…
-
CLINICAL_TRIALS withdrawal · 2016-04-21Clinical Trial Update: Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity [Phase 2]
A Phase 2 trial of photodynamic therapy using HPPH for squamous cell carcinomas of the lip, oral cavity, and oropharynx has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: Adaptive, Image-guided, Intensity-modulated Radiotherapy for Head and Neck Cancer in the Reduced Volumes of Elective Neck [Phase 2]
Phase 2 trial investigating adaptive, image-guided radiotherapy with intensity-modulated radiotherapy for head and neck squamous cell carcin…
-
CLINICAL_TRIALS trial_result · 2015-05-19Clinical Trial Update: Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 clinical trial update for depsipeptide in unresectable recurrent or metastatic squamous cell carcinoma of the head and neck; study c…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer [Phase 2]
A Phase 2 trial evaluating lapatinib ditosylate in patients with metastatic or recurrent head and neck cancer has been completed.
-
CLINICAL_TRIALS withdrawal · 2013-11-08Clinical Trial Update: S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer [Phase 2]
The Phase 2 trial S0225 evaluating capecitabine in patients who underwent surgery for locally recurrent or persistent head and neck squamous…